AzTrials
AzTrials

Neurologic DisorderNCT06932978

The Use of Smart Glasses for Environmental Controls

A study of Neurologic Disorder, run by NHS Lothian at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Environmental control systems are a type of assistive technology that can be controlled by a wide variety of different methods (e.g. switches) and can assist people with physical disabilities to control various electronic devices in the home. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Neurologic Disorder
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
1 siteUnited Kingdom
Study dates
1 May 2024to 1 Aug 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Existing environmental control system user (age 18-80).
  • Neurological condition.
  • Cognitive ability to answer the questions and to give consent.
  • Current environmental control system is compatible with smart glasses display.

Who cannot join

  • Current environmental control system or communication aid is not compatible with smart glasses display.
  • Rapidly deteriorating condition

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • SMART Centre, Astley Ainslie Hospital

    Edinburgh, EH9 2HL

Other trials in United Kingdom

About this study

Official title: The Impact of Smart Glasses on the Usability and Satisfaction of Operating an Environmental Control System or Communication Aid

Environmental control systems are a type of assistive technology that can be controlled by a wide variety of different methods (e.g. switches) and can assist people with physical disabilities to control various electronic devices in the home. Communication aids are designed to assist people who have difficulties speaking to communicate. Both systems are designed to provide independence and potentially could have a positive effect on quality of life.

The majority of communication aid and environmental control systems aimed at high end users require a screen to be mounted in front of the user. The limitations with this are that the user is only able to access their device when it has been suitably mounted in front of them. There are occasions when mounting devices in front of the user is difficult due to other considerations for example transfers in and out of a wheelchair. As smart glasses can potentially be worn at all times during the day this could provide an effective alternative solution.

Read more

The purpose of this study is to explore with service users the usability and satisfaction provided by smart glasses when operating a communication aid/environmental control system. The study will achieve the above aim by undertaking a satisfaction questionnaire prior and post a 3 week trial of using smart glasses with their device. In addition an interview will be carried out with participants to explore the impact that smart glasses has had on the usability of their device.

Participants will be recruited by contacting eligible patients of the NHS Lothian Environmental Control Service and communication aid service. The end point of the study will be 8 months from the start date (allowing for follow up data to be collected for anyone recruited towards the end of the 6-month recruitment period).

Being tested
Provision of smart glasses for environmental control use
Keywords
Environmental controls, Smart glasses, Activities of daily living, self-help devices, wearable technology
Medical subject headings
Nervous System Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Provision of smart glasses for environmental control useDevice

    To the authors knowledge there has not been a clinical trial that includes the use of smart glasses with environmental controls. The smart glasses were used with environmental control systems that had a USB-C display output.

Study groups in NCT06932978
Study groupRoleWhat they receive
Smart glassesExperimentalThe participant will be provided with a set of smart glasses (X-REAL Air 2) as an alternative display for their existing environmental control system. They will have the smart glasses to trial for a period of 3 weeks.
Receives: Device: Provision of smart glasses for environmental control use

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Quest Device Score From Baseline to Post-intervention

    The QUEST 2.0 is a 12-item instrument that measures user satisfaction with assistive technology devices and related services. Each item is scored from 1 to 5, where 1 indicates the lowest satisfaction and 5 indicates the highest satisfaction. The instrument includes 8 device items and 4 service items. In this study, only the 8 device items were administered because the focus was on the assistive technology device itself. The QUEST Device Score was calculated as the mean of the 8 device item scores, producing a possible total score range from 1.0 (lowest satisfaction) to 5.0 (highest satisfaction). The outcome represents the change in QUEST Device Score, defined as the difference between baseline and the score obtained at the end of the 3-week smart-glasses trial.

    Measured: Baseline to 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2025
  2. Study start1 May 2024
  3. Primary completion1 Aug 2024
  4. Study completion1 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06932978
Sponsor's protocol ID
AC24008
Other IDs
24/NW/0057
Status last verified
Jan 2026
First submitted
10 Apr 2025
Last updated
13 Apr 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Not required. A summary of the data in an anonymised form is sufficient.

Questions about this trial

What is this clinical trial studying?

A study of Neurologic Disorder, run by NHS Lothian at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 13 Apr 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Quest Device Score From Baseline to Post-intervention (time frame: Baseline to 3 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in